I highly recommend reading the just-released in-depth study of 51 Pharmaceutical Digital presences , a research report compiled by L2 (Luxury Lab) and PhD Media.
The review is quite well done in having a range of principled dimensions on which to rank a pharmaceutical brand’s online presence. These include:
• Website platform (brand translation, site functional elements)
• Off platform messaging (online advertising, mobile, email)
• Search engine optimization (keywords, search architecture, authority)
• Social media (dabbling in facebook, twitter, youtube, user generated content)
Within the study, products are reviewed by therapeutic category for meaningful comparisons.Note that the emphasis of this study is consumers and patients, rather than resources for healthcare professionals.
Brands are scored numerically, and given competence categories having catchy names like "genius," "gifted," or "challenged." To me, the rankings and categories are secondary, for each brand may change over time. What is important is a systematic process for taking into account the overall consumer pharmaceutical digital experience.
For a CRM perspective, this framework is valuable in that it recognizes that patients seeking healthcare information online are navigating through a broad array of digital channels. This matrix of channels: mobile, search, email, social media, and website must be integrated into an overall experience that provides health education, encourages consultation with licensed healthcare professionals and leads to better medical outcomes.
